BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15614845)

  • 1. Does nuchal translucency have a role in fetal cardiac screening?
    Hyett J
    Prenat Diagn; 2004 Dec; 24(13):1130-5. PubMed ID: 15614845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
    McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
    Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal cardiac anomalies and genetic syndromes.
    Pajkrt E; Weisz B; Firth HV; Chitty LS
    Prenat Diagn; 2004 Dec; 24(13):1104-15. PubMed ID: 15614851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of fetuses with increased nuchal translucency.
    Bilardo CM; Müller MA; Pajkrt E
    Curr Opin Obstet Gynecol; 2001 Apr; 13(2):169-74. PubMed ID: 11315872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuchal translucency and fetal cardiac malformations.
    Axt-Fliedner R; Gembruch U
    Ultraschall Med; 2010 Apr; 31(2):144-50. PubMed ID: 20094976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
    Becker R; Wegner RD
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester screening for structural fetal abnormalities: nuchal translucency sonography.
    Devine PC; Malone FD
    Semin Perinatol; 1999 Oct; 23(5):382-92. PubMed ID: 10551791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal echocardiography at the time of the nuchal translucency scan.
    Lombardi CM; Bellotti M; Fesslova V; Cappellini A
    Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
    Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of structural cardiac defects.
    Allan L
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):73-6. PubMed ID: 17304544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pregnancy outcome in 1,252 fetuses after nuchal translucency measurement in the 1st trimester].
    Horner E; Holzgreve W; Batucan C; Tercanli S
    Praxis (Bern 1994); 2002 Feb; 91(7):261-5. PubMed ID: 11883361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased fetal nuchal translucency: possible involvement of early cardiac failure.
    Montenegro N; Matias A; Areias JC; Castedo S; Barros H
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):265-8. PubMed ID: 9383878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nuchal translucency and congenital heart disease.
    Mogra R; Alabbad N; Hyett J
    Early Hum Dev; 2012 May; 88(5):261-7. PubMed ID: 22482746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Down's syndrome. Nuchal translucency screening may help detect congenital heart disease.
    Simpson JM
    BMJ; 2002 Jan; 324(7329):112. PubMed ID: 11808525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.